Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Capital Expenditures (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Capital Expenditures data on record, last reported at $3.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 93.36% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $9.4 million, up 19.76%, while the annual FY2025 figure was $8.2 million, 13.88% down from the prior year.
  • Capital Expenditures reached $3.0 million in Q4 2025 per PBH's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.9 million in Q1 2021 and bottomed at $838000.0 in Q2 2025.
  • Average Capital Expenditures over 5 years is $2.3 million, with a median of $2.2 million recorded in 2021.
  • Peak YoY movement for Capital Expenditures: tumbled 69.64% in 2021, then skyrocketed 93.36% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $2.2 million in 2021, then decreased by 19.11% to $1.8 million in 2022, then grew by 10.7% to $2.0 million in 2023, then fell by 21.54% to $1.6 million in 2024, then surged by 93.36% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $3.0 million in Q4 2025, $2.1 million in Q3 2025, and $838000.0 in Q2 2025.